Sudha Visvanathan

Years Active: 2019-2019
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Sudha Visvanathan, Stefan Daniluk, Rafał Ptaszyński, Ulf Müller-Ladner, Meera Ramanujam, Bernd Rosenstock, Anastasia G Eleftheraki, Richard Vinisko, Alena Petříková, Herbert Kellner, Eva Dokoupilova, Brygida Kwiatkowska, Rieke Alten, Christian Schwabe, Patrick Baum, David Joseph, Jay S Fine, Steven J Padula, Jürgen Steffgen
Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study. Annals of the rheumatic diseases 78 (6) (2019)
Brian Skaug, Zsuzsanna H McMahan, William R Swindell, Monique E Hinchcliff, Tracy M Frech, Virginia D Steen, Faye N Hant, Jessica K Gordon, Ami A Shah, Lisha Zhu, W Jim Zheng, Jeffrey L Browning, Alexander M S Barron, Minghua Wu, Sudha Visvanathan, Patrick Baum, Jennifer M Franks, Michael L Whitfield, Victoria K Shanmugam, Robyn T Domsic, Flavia V Castelino, Elana J Bernstein, Nancy Wareing, Marka A Lyons, Jun Ying, Julio Charles, Maureen D Mayes, Shervin Assassi
Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile. Annals of the rheumatic diseases 79 (3) (2019)

Sudha Visvanathan.css-eqlu8i{font-size:small;padding-left:4px;}